share_log

科创板晚报|五矿新能、百奥泰等6家公司发布减持计划 纵横股份收四川证监局行政监管措施决定书

Star Evening News | Minmetals New Energy, Bio-Thera Solutions, and 6 other companies announced their shareholding reduction plans. Vertical and horizontal shares receive an administrative supervision decision letter from Sichuan Securities Regulatory Bure

cls.cn ·  Oct 14 09:02

①Guangdong may introduce demonstration clauses for technology insurance such as biomedical, integrated circuits, etc.; ②Shenzhen: accelerating the establishment of a billion-level investment fund for semiconductor and integrated circuit industries in Shenzhen; ③Shanghai Stock Exchange terminates the review of Feixiang Technology's STAR Market IPO.

The Science and Technology Innovation Board Daily News on October 14th: Today's evening news on the Science and Technology Innovation Board mainly includes: Guangdong may introduce demonstration clauses for technology insurance such as biomedical, integrated circuits, etc.; Shenzhen: accelerating the establishment of a billion-level investment fund for semiconductor and integrated circuit industries in Shenzhen; Shanghai Stock Exchange terminates the review of Feixiang Technology's STAR Market IPO.

Focus on hot topics

Briefs:

Vice Minister of Industry and Information Technology Wang Jiangping: Increase financial support for unicorn companies, support unicorn companies listing, mergers and restructuring.

Deputy Minister Wang Jiangping of the Ministry of Industry and Information Technology stated today at a press conference that the Ministry will take the following measures to promote and support the development of unicorn enterprises in China. First, establish a national unified and inter-provincial unicorn enterprise nurturing system. Second, support technical innovation of unicorn enterprises, encourage and guide them to carry out technological breakthroughs around national strategic needs, and master more unique skills. Third, increase financial support for unicorn enterprises, leverage the role of industry-finance cooperation platforms, and support unicorn enterprises in listing, mergers, and restructuring. Fourth, make forward-looking arrangements for future industries, focus on new areas such as atomic-level manufacturing, brain-computer interfaces, 6G, etc., and develop and strengthen unicorn enterprises. Fifth, support unicorn enterprises in integrating into the global innovation network and engaging in innovative collaborations. We welcome international innovation teams to start businesses in China, and we also welcome foreign investment in unicorn enterprises in China. We are willing to share with the world the development opportunities of innovation and entrepreneurship in China.

Guangdong may introduce technology insurance demonstration clauses such as biomedical and integrated circuits.

Journalists learned from the industry that Guangdong province attaches great importance to science and technology finance, innovatively explores around technology insurance, and actively promotes the formulation and implementation of industry terms for demonstration clauses of technology insurance, making technology insurance one of the important means for the high-quality development of science and technology finance in Guangdong. Several professionals from Guangdong property insurance companies stated that the Guangdong Provincial Department of Science and Technology had previously exchanged information with Guangdong property insurance institutions to understand the risk protection measures and product situations in various technology fields. Currently, specific feedback on multiple technology insurance demonstration clauses has been submitted to the Guangdong Insurance Industry Association by the business departments.

Shenzhen: Speeding up the establishment of a billion-level Shenzhen semiconductor and integrated circuit industry investment fund.

The Shenzhen Municipal Government Information Office held a press conference on October 14 to introduce the relevant information of the '2024 Bay Area Semiconductor Industry Ecological Expo.' Zhu Yun, Deputy Director of the Shenzhen Development and Reform Commission, expressed that in aggregating industry resources, the establishment of the Shenzhen Semiconductor and Integrated Circuit Industry Alliance has been formed. Focusing on the landing of major projects, high-level construction of integrated circuit professional parks, attracting upstream and downstream supporting companies to gather, gradually transforming from 'point-like major project sites' to 'integrated circuit professional parks.' At the same time, strengthening financial support, setting up 38 integrated circuit-related funds with a total size exceeding 100 billion yuan through the city's investment fund contributions, leveraging social capital. Accelerating the establishment of a billion-level Shenzhen semiconductor and integrated circuit industry investment fund, and promoting a batch of integrated circuit projects to obtain local government special bonds in 2024.

Jiangsu Suzhou: Support up to 0.2 billion yuan for the construction of key smart vehicle networking laboratories.

The 6th Global Intelligent Driving Conference and Suzhou Intelligent Connected Vehicles 'Vehicle-Infrastructure Cloud Integration' Application Pilot Promotion Meeting was held in Suzhou, Jiangsu on October 14. It is understood that Suzhou is striving to build a high-level smart vehicle networking laboratory system, providing up to 0.2 billion yuan in funding support for national key laboratories in the smart vehicle networking field. Currently, Suzhou has introduced a batch of high-end scientific research institutions such as Tsinghua University's Automotive Research Institute, released over a hundred innovative products, formulated 6 international standards, built an industry chain ecosystem with smart automobile information exchange at its core, gathered more than 600 smart vehicle networking related companies, with an industry scale exceeding 60 billion yuan, completed 595.8 kilometers of intelligent connected roads, and established over 100 application scenarios.

Shanghai Fengxian introduces industrial promotion suggestions, planning to achieve a growth rate of over 70% in the number of specialized, special and new enterprises by 2027.

Fengxian District People's Government issued 'Several Opinions on Promoting the Development of Scientific and Technological Innovation to Enhance New Productive Forces and Promote the High-quality Development of Industries,' setting policy directions for promoting scientific and technological innovation, developing new productive forces, and promoting the high-quality development of industries in the region, with specific targets for the next three years. Striving to achieve that by 2027, the added value of above-scale industrial output surpasses 360 billion yuan; the total number of specialized, special, and new enterprises reaches 1,500, with the proportion of strategic emerging industries reaching 50%; adding 5 distinctive and influential industrial landmarks; the output value of the four leading industries reaches 250 billion yuan; adding 10 champions in individual fields, unicorns, and companies listed on the Science and Technology Innovation Board, with over 2,600 national high-tech enterprises; government-guided funds leveraging over 30 billion yuan in scale, investing in over 100 technological innovation projects, and more.

In-depth analysis:

Overseas short essay disrupting AI faith? GPU bubble theory is raging, the truth is...

Ma Daojie resigns as the chairman of unigroup guoxin microelectronics, and will fully promote the listing of Unigroup Spreadtrum.

Shandong's humanoid robot! Provincial and municipal state-owned asset platforms successively invested in Boldtek.

Announcement of the Science and Technology Innovation Board

Zongheng Shares: Received the administrative supervision measures decision of sichuan Securities Regulatory Bureau.

Zongheng shares announcement, the company, Ren Bin, Liu Peng, and Li Xiaoyan received a warning letter from the sichuan securities regulatory bureau, indicating that the company had insufficient provision for some bad debts of accounts receivable and issues with recognizing revenue across periods. The sichuan securities regulatory bureau decided to take administrative regulatory measures by issuing a warning letter to the company, Ren Bin, Liu Peng, and Li Xiaoyan.

6 companies have released announcements of shareholding reduction plans.

MMG New Energy announced that the company recently received the Shareholding Reduction Plan Notice Letter issued by Shenzhen Anyan Investment Partnership Enterprise. Due to its own capital needs, Shenzhen Anyan plans to reduce its total holding of company shares by not more than 57.8765 million shares within three months after 15 trading days from the disclosure date through block trades and bulk trades, with the reduction ratio not exceeding 3% of the company's total share capital.

Zhongzi Technology announced that, due to its own capital needs, Silver Anling Ying and Ying An Zhonghua plan to reduce their company's shares through block trading and bulk trading totaling no more than 3.6073 million shares, which is no more than 3.00% of the total share capital of the company.

Bio-Thera Solutions announced that Dongtai Qiheng plans to reduce its holdings of the company's shares through centralized bidding and block trading due to the exit of investment projects and the need for capital arrangement, with a total of no more than 8,281,600 shares, accounting for no more than 2% of the total share capital of the company.

VeriSilicon announcement, Gongqingcheng Keyuan and its concerted action parties intend to reduce the company's shareholding by no more than 6,371,919 shares through centralized bidding and block trading, not exceeding 1.50% of the total share capital of the company.

Announcement from Traffic Control Technology, shareholder Zhang Ou plans to reduce his holding of up to 2,735,700 shares of the company through centralized bidding from November 6, 2024 to February 5, 2025, not exceeding 1.45% of the total share capital.

Bang Yan Technology announced that shareholders Zhongyan Venture Capital plan to reduce their holdings by no more than 0.25 million shares, accounting for 0.16% of the total share capital; Zhuhai Ruixin plans to reduce their holdings by no more than 0.1 million shares, accounting for 0.066% of the total share capital; Bao Chuang Investment plans to reduce their holdings by no more than 0.25 million shares, accounting for 0.16% of the total share capital; Zhong Guang Yuan plans to reduce their holdings by no more than 0.1 million shares, accounting for 0.066% of the total share capital; Dongguan Zhongke plans to reduce their holdings by no more than 0.1 million shares, accounting for 0.066% of the total share capital; TouKong Donghai plans to reduce their holdings by no more than 0.25 million shares, accounting for 0.16% of the total share capital.

Obi Zhongguang: It is expected to incur a loss of 61 million yuan in the first three quarters, a decrease from the same period last year.

Obi Zhongguang announced that the company is expected to incur a net loss of approximately 7.2 million yuan in the third quarter of 2024, a decrease in loss of approximately 86.08% compared to the same period last year; it is expected to incur a net loss of approximately 61 million yuan in the first three quarters of 2024, a decrease in loss of around 0.131 billion yuan, a decrease in loss of approximately 68.22% compared to the same period last year. During the reporting period, the continuous implementation of the 'technology innovation investment - commercial achievement transformation' strategy has achieved good results, and the company's operational level and profitability have shown a improving trend quarter by quarter.

Wemesh: Plans to repurchase shares worth 50 million to 0.1 billion yuan.

Wemesh announced that the company plans to repurchase shares through centralized bidding trading, with the repurchase amount not less than 50 million yuan and not exceeding 0.1 billion yuan, with the source of funds from the oversubscribed funds from the company's initial public offering. The repurchased shares will be used for employee stock ownership plans or stock-based incentives, as well as to reduce registered capital. The repurchase price will not exceed 35 yuan per share, and the repurchase period is within 12 months from the date of approval by the shareholders' meeting.

Appotronics Corporation: Received the second development designation notice from BAIC New Energy.

Appotronics Corporation announced that the company recently received the second development designation notice from BAIC New Energy, once again becoming its supplier of in-vehicle optical solutions, providing intelligent cockpit display products for the Senova new car model.

Changyong Communications: Signed a termination agreement with Yangtze Optical Fibre and Cable Joint Stock.

Changyingtong announced that the company has signed a termination agreement with yangtze optical fibre and cable joint stock, and will no longer fulfill the delivery obligation of maintaining polarized optical fiber for yangtze optical fibre and cable joint stock from 2023 to 2025. The company will bear a total of 15 million yuan in breach of contract compensation to yangtze optical fibre and cable joint stock in accordance with the framework agreement terms. This liability amount will be deducted from the 15 million yuan deposit already paid to yangtze optical fibre and cable joint stock by Changyingtong (of which 5 million yuan has been deducted in 2023). Preliminary calculations show that signing the termination agreement this time will result in a decrease of 9 million yuan in the company's total profit in 2024.

Notai Biotech: Compound Picosulfate Sodium Granules Obtains Drug Registration Certificate

Notai Biotech announced that the company recently received the Drug Registration Certificate for Compound Picosulfate Sodium Granules issued by the National Medical Products Administration. The product is a compound formulation composed of Picosulfate Sodium, Magnesium Oxide, and Citric Acid, used for radiographic examination, endoscopic examination, or preoperative bowel cleansing. The product features small volume of liquid medication, good colon cleansing effect, and few adverse reactions. The approval of this product fills the gap in the company's digestive system disease drug pipeline, further enriching the company's independently developed formulation product line. However, the specific sales situation is affected by market conditions and other factors, leading to uncertainty regarding the company's short-term operational performance.

【Review Status】

Shanghai Stock Exchange Terminates the Review of Feixiang Technology's STAR Market Listing

Due to the withdrawal of the application for listing by Shenzhen Feixiang Technology Co., Ltd. and its sponsor China Merchants Securities Co., Ltd., the Shanghai Stock Exchange has terminated the review of its STAR Market listing.

Bb23T2nx47.png

Venture Capital Wind Vane

Shenshi Technology has completed a multi-billion C+ round of financing.

Beijing Shenshi Technology Co., Ltd. (referred to as Shenshi Technology) has recently completed a multi-million RMB C+ round of financing. This round of financing was jointly participated by Beijing Centergate Technologies, Shunxi Fund, and Shenzhen Lan Ying Second Phase Investment Partnership Enterprise (limited partnership). Shenshi Technology is a leader in the "AI for Science" scientific research paradigm, using artificial intelligence and molecular simulation algorithms, combined with advanced computing methods to solve important scientific problems, creating a new generation of micro-scale industrial design and simulation platform for the fields of biomedical, energy, materials, and more. This round of financing will be used to further promote its technological research and development and market expansion. Previously, Shenshi Technology has completed angel rounds, Pre-A rounds, A rounds, B rounds, and C rounds of financing, with investments from well-known institutions such as Sequoia China and Hillhouse Capital.

Xinbida has completed about a billion RMB A+ round of financing.

Wuhan Xinbida Microelectronics Co., Ltd. recently completed a billion RMB A+ round of financing, with investments from New Micro Capital and Optics Valley Golden Control. This round of financing will be used to further drive the company's research and development and market expansion in the automotive chip field. Xinbida focuses on the automotive chip industry, with main business segments including automotive power management chips, analog chips, system basic chips SBC, domain controllers, and automotive wireless connection chips, among others. The company previously completed angel rounds, Pre-A rounds, and A rounds of financing.

Aurora Mobile has completed a multi-billion A+ round of financing.

Peking Aurora Star Communications Technology Co., Ltd. has recently completed a multi-million RMB Series A+ financing. This round of financing was jointly participated by Optics Valley Industrial Investment, Huazhen Capital, Furong Investment, PwC, Rongdao Investment, Yangtze River Capital, Yarun Capital, Yarui Capital, and Black Horse Fund. The financing funds will be used for Aurora Star Communications' product research and development, market expansion, and team building in the aerospace optical communication field. Aurora Star Communications was established in 2020, focusing on the research and manufacturing of high-bandwidth, high-reliability, high-security, low-cost laser communication terminals, providing users with a series of products and system-level solutions. The company has previously completed Pre-A and Series A financing.

Ruijian Pharmaceuticals has completed a multi-million RMB Series B financing.

Wuhan Ruijian Pharmaceutical Technology Co., Ltd. announced the completion of a multi-million RMB Series B financing. This round of financing was jointly participated by National Life Capital, Ceyuan Capital, and Optics Valley Industrial Investment. The financing funds will be used to accelerate the company's research and development process in the areas of small molecule drugs, biopharmaceuticals, and innovative drugs, further promoting the commercialization process of its universal cell drugs. Ruijian Pharmaceuticals is a high-tech pharmaceutical company focusing on the efficient chemical induction of functional cell regeneration with small molecules, with its research and development technology platform based on small molecule chemical induction, dedicated to developing universal cell drugs with independent intellectual property rights to treat specific degenerative, traumatic diseases, tumors, and metabolic system diseases. Previously, Ruijian Pharmaceuticals has completed Angel Round, Pre-A Round, and Series A financing, with investments from well-known institutions such as Sequoia China and DeepVC.

Shanghai Zhuoyide Robot Co., Ltd. has completed a 0.1 billion RMB financing recently.

Recently, Shanghai Zhuoyide Robot Co., Ltd. completed a 0.1 billion RMB financing. Zhuoyide was founded in 2021, and the company's founder Li Qing has been engaged in humanoid robot-related research for 20 years. In November 2015, he led the team to develop the 'Walker No. 1' robot, which walked continuously for 134.03 kilometers and was certified by the Guinness World Records. Subsequently, he began developing the 'Xiaobei' humanoid robot, which underwent 4 iterations. 'Xiaobei 4.0' is 1.6 meters tall, weighs only 28 kilograms, and has a battery life of up to 6 hours.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment